TY  - GEN
AU  - Brummer,Christina
AU  - Faerber,Stephanie
AU  - Bruss,Christina
AU  - Blank,Christian
AU  - Lacroix,Ruben
AU  - Haferkamp,Sebastian
AU  - Herr,Wolfgang
AU  - Kreutz,Marina
AU  - Renner,Kathrin
TI  - Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma
SN  - 1872-7980
PY  - 2019///1101
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Apoptosis
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Diclofenac
KW  - analogs & derivatives
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Energy Metabolism
KW  - Genetic Predisposition to Disease
KW  - Humans
KW  - Melanoma
KW  - drug therapy
KW  - Mitogen-Activated Protein Kinases
KW  - antagonists & inhibitors
KW  - Mutation
KW  - Phenotype
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins B-raf
KW  - Signal Transduction
KW  - Skin Neoplasms
KW  - Time Factors
KW  - Vemurafenib
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2018.11.018
ER  -